{"symbol": "RGNX", "companyName": "REGENXBIO Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.regenxbio.com", "description": "Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.", "CEO": "Kenneth T. Mills", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}